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Abstract
Inflammation, airway hyper-responsiveness and airway remodelling are well-established hallmarks of asthma, but their
inter-relationships remain elusive. In order to obtain a better understanding of their inter-dependence, we develop a
mechanochemical morphoelastic model of the airway wall accounting for local volume changes in airway smooth muscle
(ASM) and extracellular matrix in response to transient inflammatory or contractile agonist challenges. We use constrained
mixture theory, together with a multiplicative decomposition of growth from the elastic deformation, to model the airway wall
as a nonlinear fibre-reinforced elastic cylinder. Local contractile agonist drives ASM cell contraction, generating mechanical
stresses in the tissue that drive further release of mitogenic mediators and contractile agonists via underlying mechanotransduc-
tive signalling pathways. Our model predictions are consistent with previously described inflammation-induced remodelling
within an axisymmetric airway geometry. Additionally, our simulations reveal novel mechanotransductive feedback by which
hyper-responsive airways exhibit increased remodelling, for example, via stress-induced release of pro-mitogenic and pro-
contractile cytokines. Simulation results also reveal emergence of a persistent contractile tone observed in asthmatics, via
either a pathological mechanotransductive feedback loop, a failure to clear agonists from the tissue, or a combination of both.
Furthermore, we identify various parameter combinations that may contribute to the existence of different asthma phenotypes,
and we illustrate a combination of factors which may predispose severe asthmatics to fatal bronchospasms.
Keywords Morphoelastic · Bronchoconstriction · Hyper-responsiveness · Mechanochemical · Airway smooth muscle ·
Multiphase
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1 Introduction
Asthma is a chronic lung disease characterized by inflamma-
tion, airway hyper-responsiveness (excessive bronchocon-
striction in response to relatively low doses of contractile
agonist; AHR) and airway remodelling. The last of these
involves a series of structural changes, including thickening
of the epithelial layer and subepithelial basement membrane
(SBM; the collagen-dominated inner layer of the airway)
and of airway smooth muscle (ASM) bundles (Holgate 2011;
Brightling et al. 2012; James et al. 2012; Berair et al. 2013).
While each of these three features contributes to asthma
severity, how they interact is poorly understood. Most impor-
tantly, it is not clear whether AHR or remodelling are causes
or consequences of the disease.
We hypothesize that while airway remodelling is initiated
by inflammatory mediators, it is perpetuated by mechani-
cal factors. The complexity of the underlying biochemical
and mechanical processes, which span multiple length and
timescales, makes identification of key interactions solely
from biological experiments on isolated processes partic-
ularly challenging. Our aim is, therefore, to investigate
the combined effect of repeated, short timescale, inflam-
matory episodes and associated mechanical forces, arising
from ASM cell (ASMC) contraction, on long-term airway
remodelling. To this end, we present a novel, quantita-
tive mechanochemical modelling framework (informed by
appropriate in vitro and in vivo studies) that integrates these
processes for the first time. We use this model to elucidate
emergent system dynamics and thereby identify key under-
lying pathogenic processes.
Although inflammation is considered to be the main pro-
cess by which airway remodelling occurs, based on in vitro
(Brightling et al. 2012; Dekkers et al. 2012; Noble et al. 2014
and references therein) and animal (Sjöberg et al. 2017; Alri-
fai et al. 2014; Silva et al. 2008; Zhu et al. 1999) studies, the
causative effects of inflammation on remodelling are not fully
supported by clinical trial or epidemiological data. For exam-
ple, controlling inflammation with inhaled corticosteroids
does not change the extent of airway remodelling or the
decline of lung function with age (Guilbert et al. 2006; Strunk
2007). Moreover, airway remodelling may occur in early life
in the absence of inflammation (James et al. 2012, 2009).
Bronchoconstriction, in the absence of inflammation, can
also promote airway remodelling (Kistemaker et al. 2014;
Oenema et al. 2013; Ge et al. 2012; Grainge et al. 2011; Tatler
et al. 2011). In addition to the structural changes present in
asthmatic airways, there is increasing evidence of altered
baseline contractile tone that is thought to be the result of
the chronic presence of contractile agonist or inflammatory
mediators (Brightling et al. 2002).
It is not clear how this persistent tone arises, but it could
enhance AHR (Bossé et al. 2009). Additionally, intra-subject
heterogeneity of tone in asthmatics has been proposed as
a cause of AHR (Brown and Togias 2016). Given that the
area fraction of ASM in human biopsies has been shown to
increase with the degree of asthma severity (Hassan et al.
2010), altered tone and ASM mass are likely interrelated.
Furthermore, airway remodelling is also associated with
extracellular matrix (ECM) changes (Kuo et al. 2011) and
SBM thickening (Benayoun et al. 2003).
Inflammation in the airways is the protective response
to allergen challenges, and is characterized by the recruit-
ment of inflammatory cells (such as eosinophils), activation
of resident mast cells, and over-expression of cytokines
and chemokines (Brightling et al. 2003). Some of the lat-
ter interact directly with ASM to trigger contraction, and/or
interact with mast cells causing them to degranulate, pro-
ducing histamine and other contractile agonists (Kostenis
and Ulven 2006). Inflammatory cells release mediators that
also have the ability to induce remodelling (e.g. TGF-
β; Halwani et al. 2011). Subsequently, the inflammatory
cells and cytokines are gradually cleared from the tissue.
Allergen challenges in humans are typically random, but
in mouse models of asthma, inflammatory and contractile
agonist challenges are administered and controlled artifi-
cially.
Tissue mechanics plays a significant role in airway remod-
elling and bronchoconstriction. For example, mechanical
strain increases ASMC proliferation (Smith et al. 1994) and
contractile protein expression (Smith et al. 1997, 1995). In
addition, TGF-β is a cytokine that mediates remodelling by
inducing both cell proliferation and ECM protein produc-
tion (Halwani et al. 2011), as well as having a potential
contractile agonist role (Desmoulière et al. 2005; Grinnell
and Ho 2002; Montesano and Orci 1988). It is activated
by ASMCs (Tatler et al. 2011), likely during bronchocon-
striction (Oenema et al. 2013; Tatler and Jenkins 2012) via
mechanical stretch from latent complexes that are tethered to
the ECM and to the ASMC (Froese et al. 2016; Noble et al.
2014; Wipff et al. 2007). Moreover, bronchial epithelial cells
under mechanical compression shed growth factors such as
endothelin-1 (ET-1), early growth response-1 (EGR-1) and
TGF-β (Tschumperlin and Drazen 2006, 2001; Tschumper-
lin et al. 2004) as well as to signal lung fibroblasts to express
ECM proteins in vitro (Swartz et al. 2001).
The heterogeneous micro-mechanical stress environment,
generated by ASM contraction, can be quantitatively and
qualitatively very different in normal versus remodelled air-
ways (Hiorns et al. 2016). Associated mechanotransductive
processes may influence ECM deposition and ASM pro-
liferation and migration. While it is recognized that these
mechanisms play a crucial role in numerous developmental,
physiological and pathological processes in other diseases
(Hoffman et al. 2011; Martinez-Lemus et al. 2009), we have
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yet to understand how these mechanisms contribute to AHR
and airway remodelling in asthma.
A significant body of work focusses on models of bron-
choconstriction (e.g. Hiorns et al. 2014; Eskandari et al.
2013; Politi et al. 2010; Wang et al. 2008; Latourelle et al.
2002; Lambert and Paré 1997; Macklem 1996; Lambert
et al. 1993), with much less attention paid to modelling
of inflammation in the airways. Of particular relevance to
this work are two of our previous models: firstly, our finite-
thickness continuum-based model (Hiorns et al. 2014) of
agonist-initiated contraction of the airway (represented as a
nonlinear fibre-reinforced elastic material), which accounts
for contractile force generation at the cell-level; secondly,
our spatially-averaged (ordinary differential equation; ODE)
model (Chernyavsky et al. 2014) of inflammation-driven
switching of ASMCs from a contractile to a proliferative
phenotype. The former predicts airway calibre changes and
spatial stress heterogeneities, as a result of ASM contrac-
tion and in response to pressure fluctuations that mimic tidal
breathing. In the latter, resolution of inflammation is impli-
cated as the key factor in driving ASM mass accumulation;
however, this model does not account for mechanotrans-
ductive feedback from mechanical stresses arising in the
constricted remodelled airway wall. Thus, we combine and
extend these two models by: (i) recasting our biomechanical
model of the contractile airway into a well-established mor-
phoelastic framework, that has been widely applied to growth
and remodelling of soft tissues; and (ii) coupling this to the
evolution of individual tissue constituents, using a multiphase
description, governed by underlying biochemical processes
such as inflammation-induced ASM phenotype switching,
ASM cell proliferation or recruitment and ECM deposition,
all of which can depend on mechanical stresses. Importantly,
this coupled model accounts for two-way feedback between
inflammation-driven changes in volume fractions of individ-
ual airway constituents and their resulting mechanochemical
environment.
2 Methods
2.1 Mathematical formulation
We model the airway wall as a two-layered cylinder, repre-
senting the inner collagenous SBM and an outer (predom-
inantly) smooth muscle layer, within which accumulation
of ASM mass and ECM deposition is driven by both bio-
chemical and mechanical stimuli (Figs. 1, 2), neglecting (for
simplicity) the sub-mucosal epithelial layer. We first outline
a description of the elastic deformation (Fig. 1), consist-
ing of the balance of linear momentum together with the
constitutive specification of a hyperelastic mechanical law
(Sect. 2.1.1). We then define the model inputs representing
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Fig. 1 Configurations during finite growth of the airway wall. Top row:
Schematic of the evolution of the airway wall geometry with time, with
the colours correspoding to tissue constituent volume fraction. Middle
rows: Schematics of the airway geometry in the grown and stressed
configurations, at the indicated time. At initial time t0, the airway wall
is defined by inner radius R1, interface radius Rint , and outer radius
R2 in κ0, the original, stress-free reference configuration. Airway wall
growth is described by the mapping, G, from the original configura-
tion to κg , the grown, zero-stress configuration, defined by grown radii
ξ1, ξint (not shown), and ξ2 at time t1. The airway is deformed via F
to configuration κ , the current, stressed configuration, defined by radii
r1, rint , and r2, subject to pressure boundary conditions P1 and P2.
Bottom row: Schematics of transmural mechanical stress distributions,
generated from the active contraction and/or the elastic deformation,
and contractile agonist. The mechanical stress, τ , modulates certain
rates in the constitutive mass balance equations, e.g. (2.18, 2.21), to
influence growth, G
biochemical stimulation (Sect. 2.1.2). Finally (Sect. 2.1.3),
we construct the mass balance equations, incorporating
suitable biochemical and mechanotransductive processes
(Fig. 2).
2.1.1 Geometry and kinematics
The airway tissue is modelled as a mixture (Ateshian 2007;
Humphrey and Rajagopal 2002; Bowen 1976; Truesdell and
Toupin 1960) consisting of four phases: ASMCs in either a
contractile (c) or a proliferative (p) phenotype; a collagen-
dominated ECM (e); and an extracellular fluid (w) that also
transports soluble nutrient (not modelled) for tissue main-
tenance. The outer layer is composed of multiple phases
(predominantly ASMCs), and the inner layer, representing
the SBM, is composed entirely of the ECM phase. Follow-
ing the traditional continuum mechanics approach (Holzapfel
2000; Truesdell and Noll 1965), we assume initially (at time
t0) that each constituent a in the airway is in a (common)
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spatial, unstressed and unstrained reference configuration
denoted κ0, in which the position of a particle is given by X.
We assume that the airway is an axisymmetric thick-walled
cylinder of fixed length. We define fixed polar cylindri-
cal co-ordinates R,Θ, Z in the radial, circumferential and
axial directions, respectively, with the inner layer occupying
R1  R  Rint, and the outer layer Rint  R  R2 (Fig. 1).
In Fig. 1, G is a topological mapping from κ0 to an interme-
diate “grown” configuration κg , in which the position of a
particle originally at X is given by ξ(X, t), with cylindrical
co-ordinates:
ξ = ξ (R, t) , ϑ = Θ, ζ = Z , (2.1)
where we have assumed the airway maintains axisymmetry
and zero axial growth. The airway in the grown configura-
tion κg is deformed to a stressed configuration κ , and the
position of a particle originally at ξ is now at x(ξ), with
the mapping given by the deformation gradient tensor F.
The total deformation is given by using the standard mul-
tiplicative decomposition, H = FG. For concision, explicit
dependence on time is suppressed here and throughout.
For simplicity, we impose a plane-strain approximation,
axisymmetry, and zero axial displacement. Thus, the defor-
mation from κg to κ is given by
r = r(ξ), θ = ϑ, z = ζ, (2.2)
so that the elastic deformation gradient tensor is given by
F = diag
[
∂r
∂ξ
, r
ξ
, λz
]
. (2.3)
Assuming incompressibility, det(F) = 1 thus gives
r2 = r2int + ξ2 − ξ2int, (2.4)
where rint = r(ξint). The initial airway geometry (Online
Resource 2) is chosen to match the bovine airways used in
LaPrad et al. (2010), from which the mechanical properties
are obtained. These are similar in size and structure to gen-
eration 4 human airways (Harvey et al. 2013; Coxson et al.
2008; Williamson et al. 2011). The interface radius is chosen
based on human airway histology (Benayoun et al. 2003).
Mechanical properties We assume the tissue is a nonlinear
hyperelastic heterogeneous (multiphase) anisotropic mate-
rial (Bowen 1976; Truesdell and Noll 1965; Truesdell and
Toupin 1960). The formulation for obtaining the constitu-
tive mechanical relation for this type of material is given in
detail by Ateshian and Ricken (2010) and Ateshian (2007).
We neglect dissipative stresses and assume: that all solid
constituents are constrained to move together (Humphrey
and Rajagopal 2002); isothermality; electroneutrality; tissue
Fig. 2 Overview of the biochemical mechanisms. Allergen or con-
tractile agonist challenges, f (t), specified to occur at times ti , drive
evolution of an inflammatory factor, μ, and contractile agonist con-
centration, k. The magnitude and rate of clearance of μ and k are
determined by constants aμ, ak , and cdμ, cdk , respectively. Inflamma-
tion leads to global release of contractile agonist at rate akμ. Contractile
agonist induces local ASMC contraction, and the resulting increased
mechanical stress τ releases further cytokines, with contractile ago-
nist properties, at rate ac. Contractile ASMCs undergo apoptosis (ca)
and switching to a proliferative phenotype (ccp). The proliferative
ASMCs divide (cp) and switch to a contractile phenotype at a (high)
constant rate (cpc). Both inflammation and mechanical stress drive
increases (from a baseline) in the contractile to proliferative switch-
ing rate (ccp(μ, τ)), and increasing mechanical stress drives increases
in the proliferation or recruitment rate (cp(τ )). ECM proteins degrade
(cde) and are deposited (cbe(μ)) at baseline rates during normal tissue
maintenance, with the latter increasing with inflammation. Proliferating
ASMCs produce additional ECM proteins (with rate cpe). Blue dot-
ted arrows indicate how constituent volume fractions are required for
computation of the mechanical stress (τ ), as illustrated in Fig. 1. Rate
constants are given in Online Resource 2
incompressibility; that stress arises from the elastic deforma-
tion only (i.e. the growth mapping does not impart stress);
and that viscous stresses are negligible.
Following Hiorns et al. (2014), we apply the commonly
used additive de-coupling of the active and passive Cauchy
stress tensors:
T = −p1 + Tpassive + Tactive, (2.5)
where 1 is the identity tensor and p is a Lagrange multiplier
enforcing incompressibility, with the passive stress given by
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Tpassive = 2F∂Ψ
∂C
FT, (2.6)
in which we highlight that, since the mixture is constrained,
Fa = F. In (2.6), Ψ is the strain energy function per unit
volume of the mixture,
Ψ =
∑
a=p,c,e
ΦaWa, (2.7)
and Wa is the strain energy function per unit constituent vol-
ume of constituent a (Ateshian 2007; Huyghe and Janssen
1997), noting that the fluid phase (w) does not contribute to
the mechanical response of the tissue.
The contractile ASMCs and collagen-dominant ECM
form continuous fibre-like structures (Ijpma et al. 2017) and
therefore are modelled as two sets of helical fibres wrapped
symmetrically about the airway axis (to avoid torsion). The
active stress in (2.5) is given by
Tactive = Φc Acm( j)c ⊗ m( j)c , (2.8)
where Ac is the contractile force density, defined as the force
generated by the contractile ASMCs per unit area of con-
stituent (Brook et al. 2010) and m( j)c is the contractile ASMC
fibre orientation vector (see Online Resource 1.1 for further
details).
Specification of the constitutive mechanical response for
the airway wall constituents In our previous work (Hiorns
et al. 2014), the airway wall is modelled as a composite mate-
rial of ASMCs and ECM, in which two families of fibres
are embedded in an isotropic ground matrix, thus giving
an anisotropic response. Fibre recruitment is modelled phe-
nomenologically with an exponential dependence on stretch.
Here, we de-couple the mechanical responses of the pro-
liferating ASMCs, modelled as an isotropic neo-Hookean
material; the contractile ASMCs, modelled as the fibre-
embedded material described above, and the ECM, modelled
similarly under the additional assumption that collagen fibres
bear load only after being extended beyond the recruitment
stretch, λu (Hiorns et al. 2014; Hill et al. 2012; Robertson
et al. 2011; Holzapfel and Ogden 2010). The strain energy
functions for each of the constituents are given in Online
Resource 1.2.
We introduce a scalar quantity τ representing the mechan-
ical stress along the contractile ASMC fibre directions, given
by
τ = 1
2
∑
j=1,2
T : m( j)c ⊗ m( j)c , (2.9)
which is used in the mass balance equations in Sect. 2.1.3
to elicit the mechanotransductive responses. The degree of
contraction is directly related to the amount of agonist bound
to the relevant contractile ASMC receptors. We therefore
assume that the contractile force density, Ac in (2.8), is a
function of contractile agonist concentration, k, saturating as
follows:
Ac = Tc k
n
Kd + kn , (2.10)
where Tc is a measure of hyper-responsiveness, Kd repre-
sents the ratio of the dissociation rate of the ligand-receptor
complex to its association rate, and n is the Hill coefficient,
describing cooperativity.
Balance of linear momentum In addition to the assump-
tions stated above, we further assume that body forces
are negligible and inertial terms may be neglected due to
slow timescales associated with quasi-static deformation.
Therefore, in mechanical equilibrium, conservation of lin-
ear momentum requires
∇ · T = 0. (2.11)
Under the assumption of no torsion and plane strain, (2.11)
reduces to
∂Trr
∂r
+ Trr − Tθθ
r
= 0, (2.12)
where Trr is the radial component and Tθθ the circumferential
component of the Cauchy stress.
Boundary conditions for the elastic deformation For the
elastic deformation, pressure boundary conditions are spec-
ified at the inner and outer radii, and continuity of radial
displacements and stress at the interface, so that
Trr (r1) = −P1, (2.13a)
r (i)(ξint) = r (o)(ξint) ≡ rint. (2.13b)
T (i)rr (rint) = T (o)rr (rint), (2.13c)
Trr (r2) = −P2. (2.13d)
2.1.2 Model inputs
We assume that a series of transitory allergen challenges
drives a global inflammatory response that represent an influx
of inflammatory cells, such as eosinophils, into the airway tis-
sue, resulting in a cumulative inflammatory status denoted μ.
The challenges may be administered (e.g. in chronic asthma
mouse models), or occur naturally. Therefore, μ evolves
according to
dμ
dt
= aμ f (t) − cdμμ, (2.14)
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where cdμ is the inflammation decay rate representing
clearance of inflammatory cytokines or inflammatory cell
apoptosis, and aμ the magnitude, and f (t) denotes the tim-
ing of events given by (2.16).
Inflammation drives a local activation of mast cells and
bronchoconstrictive mediators (represented by the concen-
tration k) such as histamine or acetylcholine (Pelaia et al.
2008). The agonist induces active contraction of the ASM,
which leads to airway narrowing together with associated
local airway wall stresses. We assume that the local ten-
sile stress, τ (2.9), induces activation of latent TGF-β; this
cytokine also acts as a contractile agonist and therefore
contributes to k. We also consider cases where local com-
pressive stress drives remodelling. These cases represent
compression-induced epithelial-cell-mediated expression of
EGR-1 or ET-1, noting that, here, we do not model the epithe-
lial cells directly.
As with inflammation, the frequency of contractile agonist
challenges may be specified as model input to represent, for
instance, artificial methacholine challenges in animals (Lau-
zon and Bates 2000; Gunst et al. 1988) or humans (Grainge
et al. 2011). Contractile agonist, k, thus evolves over time
according to
dk
dt
= ak f (t) − cdkk + akμμ + acτ H(τ ), (2.15)
where cdk is the agonist clearance rate, ak the magnitude of
administered agonist stimuli, akμ the rate of inflammation-
induced agonist activation, and ac the rate at which the
stress τ induces agonist release. The Heaviside step function
H ensures that only tensile stresses release k (Wipff et al.
2007).
By setting aμ = 0 or ak = 0 in 2.14 and 2.15, f (t)
represents either contractile agonist- or inflammatory-only
challenges, respectively. The challenges are represented by
a series of Gaussian peaks
f (t) = 1√
2πσ 2
N∑
i=1
[
exp−d(t−ti )2/2σ 2
]
, (2.16)
where ti is a vector of N event times, and d and σ are con-
stants (Chernyavsky et al. 2014).
2.1.3 Tissue growth
Under the assumption of axisymmetry, in cylindrical polar
co-ordinates, the local density, ρa, of each constituent (a =
c, p, e, w) evolves according to:
∂ρa
∂t
+ v ∂ρa
∂ξ
+ ρa 1
ξ
∂(ξv)
∂ξ
= sa (2.17)
where ρa and the (constrained mixture) radial growth veloc-
ity, v, are functions of the grown radius, ξ (Fig. 1), and time,
t ; sa = sa
(
ρc, ρp, ρe
)
represents the constituent-dependent
source/sink terms, specified in detail below.
We assume that the density of contractile ASMCs, ρc,
evolves through switching to and from a proliferative pheno-
type, ρp (Fig. 2; Naveed et al. 2017; Wright et al. 2013; Hirota
et al. 2009). The definition of ASMC phenotype is based on
the observable function of the cells arising from expression
of intracellular proteins, e.g. proliferative ASMCs exhibiting
decreased expression of contractile proteins (Wright et al.
2013). As in our previous model (Chernyavsky et al. 2014),
the rate of switching is governed by the inflammatory status,
μ, but here we additionally assume that switching can also
be driven by the local fibre mechanical stress τ . Thus,
sc = cpcρp − caρ2c − ccp (μ, τ) ρc, (2.18)
where cpc and ca are positive constants, the first two terms
representing switch back from the proliferative phenotype
and apoptosis, respectively, the combination of which pro-
vides a logistic growth representation. ccp represents the
inflammation- and stress-modulated rate of switching to the
proliferative phenotype given by
ccp(μ, τ) = cc0 + (cc1 − cc0) H(μ − μ1)
+ (cc2 − cc1) H(μ − μ2) + ccτ (τ )τ, (2.19)
where cc0, cc1, cc2 and ccτ are positive constants. The Heav-
iside functions are used to divide the inflammation into three
levels: healthy, mild, and severe, which are characterized by
the thresholds μ1 and μ2 (Fig. 3). The final term represents
local mechanical stress-induced switching:
Fig. 3 Inflammation levels. Inflammatory status dynamics induced
by a series of environmental stimuli, illustrating the parameters
μ1, μ2, aμ, cdμ, and ti , noting that for periodic events, ti+1 − ti = Δt
and ω = 1/Δt . The solid line represents relatively fast inflammatory
clearance (high cdμ), while the dotted line represents slow clearance
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ccτ (τ ) =
⎧
⎨
⎩
c
f
cp H(τ ) if tension induces switching,
c
f
cp H(−τ) if compression induces switching.
(2.20)
Increases in proliferative ASMC density, ρp, arise via
proliferation and phenotype switching. Thus, proliferative
ASMC turnover, sp, is represented by
sp =
(
cp(τ ) − cpc
)
ρp + ccp(μ, τ)ρc, (2.21)
where the proliferation rate (cp(τ )) is modulated directly by
the local stress τ according to
cp(τ ) = cp0 + cpτ τ, (2.22)
representing baseline and a (tensile or compressive) stress-
driven proliferation, of identical form to (2.20) but with rate
constant c fp .
ECM turnover is modelled via
se = cpeρp + cbe(μ) − cdeρe, (2.23)
where the first term represents ECM synthesis by the prolif-
erative ASMCs, e.g. via ASMC-mediated release of active
TGF-β that induces ASMCs to synthesize collagen (Coutts
et al. 2001); the second term represents modification of
ECM by inflammatory mediators, e.g. via mast cell activation
mediated by MMP-1; and the third term, linear degradation.
The inflammation-driven ECM deposition is given by
cbe(μ) = ce0 + (ce1 − ce0) H(μ − μ1)
+ (ce2 − ce1) H(μ − μ2), (2.24)
where, again, the Heaviside function is used to separate the
three inflammation levels.
For simplicity, each of the constituents is considered
intrinsically incompressible, i.e. their true densities (ρTa )
remain constant in space and time (Ateshian 2011), and we
assume that the true densities of the ASMCs and ECM are
equal, a reasonable assumption in general (Gleason et al.
2004). In the following, we work in terms of the volume
fraction, defined by Φa = ρa/ρTa , and correspondingly write
the source/sink terms as Sa = sa/ρTa . Assuming no voids, we
obtain
∑
a
Φa = 1. (2.25)
Equation (2.17), together with the definition of volume
fraction and the source/sink terms, is re-expressed as
∂Φa
∂t
+ v ∂Φa
∂ξ
+ Φa
(
1
ξ
∂
∂ξ
(ξv)
)
= Sa (2.26)
where the volume fractions, Φa, are functions of the grown
radius, ξ (Fig. 1), and time, t , and a = c, p, e. As in Gleason
et al. (2004), we assume that a constant and uniform tissue
hydration is maintained, such that Φw = 0.70. Summation of
(2.26), together with (2.25), gives the mass balance equation
for the entire mixture as
1
ξ
∂
∂ξ
(ξv) = (Sc + Sp + Se
)
/ (1 − Φw) = q. (2.27)
We note that: Φe is obtained using (2.25); Sc, Sp and Se
are functions of Φc, Φp and Φe. Thus (2.25), (2.27) and
(2.26), together with initial conditions on Φa (see Online
Resource 2), ξ and boundary conditions on v, completely
specify the time-evolving growth mapping G, provided
that the mechanical stress state can be computed (Fig. 1;
Sect. 2.1.1).
Initial and boundary conditions on tissue growth During
normal tissue maintenance, in the absence of inflammation
or administered contractile agonist, we assume that ASM
proliferation, recruitment and apoptosis, and ECM degrada-
tion and deposition in the airway wall balance to generate a
homeostatic state. The non-trivial homogeneous steady state
for (2.26), for which v = 0, is given by
Φ∗p =
cpc
2
c0
ca(cpc − cp0)2ρTp
, (2.28a)
Φ∗c =
cp0cc0
ca(cpc − cp0)ρTc
, (2.28b)
Φ∗e =
ce0 + cpeΦ∗pρTp
cdeρTe
, (2.28c)
where we have made use of (2.18), (2.21), and (2.23). A linear
stability analysis of (2.26) ensures a priori that the steady
state (2.28) is stable. Hence, we impose this homeostatic
steady state as the initial condition
Φa(ξ, 0) = Φ∗a , a = c, p, e. (2.29)
A zero flux condition is imposed at the inner wall and
at the interface between the two layers, which in cylindrical
polar co-ordinates is given by
v(ξ1)
∂Φa
∂ξ
∣∣∣∣
ξ1
= 0, (2.30a)
v(ξint)
∂Φa
∂ξ
∣∣∣∣
ξint
= 0. (2.30b)
In order to solve the ODE (2.27) representing growth in
each layer, a boundary condition must be specified on the
velocity. However, because (2.27) is first order, one is unable
to specify the velocity at both the inner and outer boundaries
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of each layer. We therefore set the radial velocity to zero on
the outer wall, so that all growth occurs inwardly (this choice
is discussed further in Sect. 4). Additionally, we require the
velocity and displacement at the interface of the two layers
to be continuous. Hence, we have
ξ(R2) = ξ2 = R2, (2.31a)
ξ(R(i)int ) = ξ(R(o)int ) = ξint, (2.31b)
v(ξ2) = 0, (2.31c)
v(ξ
(i)
int ) = v(ξ (o)int ), (2.31d)
where the superscripts (i) and (o) denote limiting values
taken from the inner and outer layers, respectively.
Inflammatory or agonist challenge protocol Episodes
of inflammation-inducing allergen or contractile agonist
challenges are represented by (2.16) in (2.14) or (2.15),
respectively. Simulations are performed over a 1000 day
interval, with the challenges confined to the first 50 days,
thereby allowing a long resolution period to investigate the
effects of the challenges on long-term airway remodelling
post-challenge. The numerical solution method is outlined
in Online Resource 1.3.
2.2 Determination of material parameters
The passive material parameters are determined by fit-
ting (2.12) to the quasi-static pressure-radius inflation data
in LaPrad et al. (2010) via nonlinear regression using
lsqcurvefit.m in MATLAB, with termination tolerances
set to default values. Material parameters are given in Online
Resource 2, and the fit to the data (R2=0.9978) is depicted
in the results below. The active response is determined
by selecting values for Tc that qualitatively matched the
active pressure-radius curves given in the work of Hiorns
et al. (2014) for similar values of contractile agonist, k. All
model parameter values and their descriptions are provided
in Online Resource 2.
3 Results
To investigate the behaviour of our novel mechanochemical
morphoelastic model, we first performed a one-at-a-time sen-
sitivity study (Online Resource 3) on selected parameters of
most relevance to airway remodelling. The analysis showed
that remodelling was most sensitive to the magnitude and
resolution rate of inflammation, during inflammatory chal-
lenges. However, due to the possible effect of combination
of the large number of parameters in this model (see Online
Resource 2) and the large differences in remodelling that
occur between inflammation and contractile agonist chal-
lenges, we chose to perform a series of paired parameter
explorations. These are used to investigate the effect of
repeated inflammatory episodes, and mechanical forces that
arise from repeated ASM contractions, on long-term airway
remodelling and effective mechanical properties of the air-
way. Parameters are set to default values unless varied in
the simulations. Results are discarded for parameter choices
that lead to airway growth or contraction completely into
the lumen, i.e. the inner radius decreases to zero. Unless
otherwise specified, remodelling occurs in the outer layer
only.
Effect of inflammatory challenges In our first set of sim-
ulations, we apply only inflammatory challenges (ak =
0), mimicking regular allergen exposures in experimental
studies, and explore the response to changes in challenge
frequency, ωμ, and inflammation resolution rate, cdμ. From
an initial inner radius of 1.8mm, we observe inward airway
remodelling towards the lumen, as depicted in Fig. 4a, show-
ing the inner radius at 5 days post-final challenge for each
parameter pair. In particular, we observe a “switch” effect,
in which the response is insensitive to increases in ωμ and
decreases in cdμ for a large region of parameter space, but
dramatic increases in remodelling occur beyond a thresh-
old parameter set. Contractile agonist retention time, defined
as the number of days between the final inflammatory or
agonist challenge and the reduction in the total amount of
agonist in the airway cross-section to near zero (< 1x10−6),
remains rather low for relatively high ωμ and low cdμ, and
is relatively insensitive to ωμ, but we observe a threshold
in cdμ below which the agonist resolution time increases
abruptly to 15 days from a baseline of approximately 10
days.
Detailed results for a specific parameter choice (high-
lighted by circles in Fig. 4a) are shown in Fig. 4b–e. Static
pressure-radius curves are computed for time points dur-
ing and following inflammatory challenges (Fig. 4b). For
these parameter choices, the contractile agonist concentra-
tion remains low, since the rate of inflammation-induced
agonist release is relatively low, and very little ASMC con-
traction occurs. During challenges, the pressure-radius curve
shifts downward as the airway thickens due to inflammation-
induced remodelling. Following challenges, the curves con-
tinue to shift slightly downwards, due to a small amount of
post-challenge remodelling, prior to a return to the steady
state.
The total amount of ASM and ECM increases during
inflammatory challenges as ASMCs switch from contrac-
tile to proliferative phenotype, and their volume fractions
relative to that of ECM increase over time (Fig. 4c, d). Rela-
tively low mechanical stresses arise during challenges for this
parameter set, as inflammation induces only a small amount
of contractile agonist release, and hence contraction is also
minimal. We observe compressive radial stresses in the air-
way mid-wall. In the circumferential direction, the stresses
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Fig. 4 Effect of inflammatory challenges on airway remodelling and
mechanics. Variation in a remodelled geometry with inflammation fre-
quency (ωμ) and resolution (cdμ) parameter values. Illustrative results
are evaluated at the circled point on the surface: b pressure–radius curve
(red lines correspond to points during challenge; blue lines indicate res-
olution period; blue dots indicate data of LaPrad et al. 2010); c volume
fraction of proliferative ASMCs (Φp) as a function of radius and time,
d Φp and e Tθθ as functions of radius at days 28, 30, and 32 (indicated
by dotted lines in c). Additional plots are provided in Online Resources
4 and 5
are found to be tensile towards the outer edge of the airway
wall and compressive near the lumen (Fig. 4e). Mechanical
stresses in the axial direction are compressive due to tissue
incompressibility (Online Resource 5).
Effect of inflammatory challenge-induced ECM changes
in the subepithelial basement membrane Next, to model
SBM thickening associated with asthma, we allow for
inflammation-induced ECM deposition and degradation in
the SBM, as well as in the outer layer, by setting ce0, ce1, ce2
and cde in the inner layer to the default values given (for
the outer layer). The addition of inflammation-induced ECM
deposition results in increased inward remodelling (Fig. 5a),
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Fig. 5 Effect of inflammatory challenge-induced subepithelial base-
ment membrane thickening on airway remodelling and mechanics.
Variation in a remodelled geometry with inflammation frequency (ωμ)
and resolution (cdμ) parameter values. Illustrative results are evaluated
at the circled point on the surface: b pressure–radius curve (red lines
correspond to points during challenge; blue lines indicate resolution
period; blue dots indicate data of LaPrad et al. 2010) and c circumfer-
ential stress (Tθθ ) as a function of radius and time. Results are similar
to Fig. 4, except here, inflammation also drives SBM thickening
which, in turn, decreases effective airway compliance, as
shown by modified pressure–radius curves (Figs. 5b, c,
f, 4b). Compressive circumferential stresses in the SBM
are correspondingly reduced (Fig. 5c), due to increased
cross-sectional area. In contrast, peak tensile circumferential
stresses in the outer layers are greater with SBM thickening,
presumably as a result of a thicker, stiffer inner layer and
therefore an effectively stiffer airway.
Effect of contractile agonist challenges Here, we apply
only contractile agonist challenges (aμ = 0), mimicking reg-
ular methacholine exposures in experimental animal studies.
We highlight that, in these simulations, all remodelling is
driven by mechanotransduction, i.e. by local, stress-mediated
phenotype switching. We find that increasing the agonist
challenge frequency (ωk) and decreasing the contractile ago-
nist resolution rate (cdk) lead to increased remodelling at 5
days post-challenge. As in the inflammatory-only challenges,
severe remodelling is observed only beyond a threshold
parameter set. Contractile agonist resolution time increases
with decreasing agonist resolution rate, cdk , with a thresh-
old below which there is a dramatic change in resolution
time from a baseline of approximately 5 days to over 60
days (Fig. 6a). The dramatic increase in resolution time is a
result of the build-up of agonist concentration demonstrated
by nonzero agonist concentrations at the end of each chal-
lenge (Online Resource 5). Similar to the inflammation-only
challenges, the contractile agonist resolution time is rela-
tively insensitive to the challenge frequency, ωk .
Despite the reduced ECM volume fraction in the outer
part of the airway (see Online Resource 5), the overall effec-
tive stiffness of the remodelled airway is increased during
contractile agonist challenges, as indicated by the contin-
ued downshift in pressure–radius curves at high transmural
pressures (Fig. 6b). To inflate the airway, a relatively high
transmural pressure is required to overcome the increased
contractile forces in the strongly contracted state, with a
strong downward shift at all pressures, and the appearance of
a significantly more compliant portion that shifts towards the
right. When the pressure is great enough to cause stretches
that exceed the recruitment threshold (see Sect. 2.1.1 and
Online Resource 1.2), there is a very rapid increase in the
recruitment of ECM. Tissue growth (increased airway thick-
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Fig. 6 Effect of contractile agonist challenges on airway remodelling
and mechanics. Variation in a agonist resolution rate with contrac-
tile agonist frequency (ωk ) and resolution (cdk ) parameter values.
Illustrative results evaluated at the circled point on the surface: b
pressure–radius curve (red lines correspond to points during challenge;
blue lines indicate resolution period; blue dots indicate data of LaPrad
et al. 2010), c contractile agonist concentration (k) as a function of
radius and time, d Φp and (e) Tθθ as functions of radius at days 28, 30,
and 32 (indicated by dotted lines on c). Additional plots are provided
in Online Resources 4 and 5
ness) also contributes to the observed downward shift. The
separation of the effects of contractile agonist and tissue
growth becomes clear following challenges, where the com-
pliant portion of the curve disappears (first curve following
challenges, Fig. 6b), and the high pressure portion of the
pressure-radius curves shifts downwards as remodelling con-
tinues post-challenge.
As contractile agonist challenges cause the airways to con-
tract (Fig. 6c), local ASMC phenotype switching (Fig. 6d)
and local release of contractile agonist increase with increas-
ing tensile circumferential stress in the outer part of the
airway wall (Fig. 6e) that arises from the agonist-induced
contraction. Small amounts of locally activated residual con-
tractile agonist continue to drive remodelling post-challenge,
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generating a feedback loop that slows agonist clearance
(Fig. 6a), accounting for build-up in agonist concentration.
Effect of changes in intrinsic ASM hyper-responsiveness
To simulate the effects of increasing intrinsic responsive-
ness of ASMCs to contractile agonist, we return to the
inflammation-only challenges and investigate the effect of
paired changes in responsiveness (Tc) and challenge fre-
quency (ωμ). We find that remodelling increases with Tc
and ωμ (Fig. 7a), but a threshold effect only exists for
increasing Tc. Increasing Tc also leads to much slower ago-
nist clearance. At low values of Tc, the agonist eventually
clears (Fig. 7a, b), while at high values, a self-perpetuating
feedback loop is established (Fig. 7a, c), due to the local
mechanotransduction-driven agonist release, which is not
resolved, and the airway eventually grows in to the lumen.
Global versus local effects of inflammatory and contrac-
tile agonist challenges In Figs. 4 and 6, we illustrate the effect
of varying frequency and resolution rate of inflammation- and
contractile agonist-only challenges, respectively. Here, we
compare instead the effects of varying amplitude and resolu-
tion rate in these globally applied challenges (first and second
columns, Fig. 8). Additionally, we compare these effects to
changes in rates of inflammation- (akμ) and stress-mediated
(ac) local contractile agonist release (third column, Fig. 8).
Increasing the amplitude (aμ) and decreasing the reso-
lution rate (cdμ) of inflammatory-only challenges lead to
increased remodelling (Fig. 8a), without a clear threshold
effect. Additionally, the degree of remodelling becomes less
dependent on the inflammation amplitude for sufficiently fast
resolution. At the (relatively low) default value of ASMC
responsiveness, Tc, employed here, the contractile agonist
clears rapidly from the tissue upon cessation of inflamma-
tory challenges, due to the small amounts of local agonist
activated by mechanical stress (Fig. 8d). Low levels of ago-
nist release during inflammatory challenges results in limited
contraction and therefore very low mechanical stresses.
In contrast, we observe a very sharp threshold for increas-
ing contractile agonist magnitude (ak ) and decreasing agonist
clearance rate (cdk) (Fig. 8b). Locally activated agonist
remains in the tissue longer at lower clearance rates, and
its effect is evident in the transmural variations in circumfer-
ential stress (Fig. 8f) in the time period following cessation
of challenges (> day 50). High contractile agonist concen-
tration induced by the agonist challenge generates significant
bronchoconstriction and therefore relatively higher mechan-
ical stresses than with inflammatory challenges.
Increasing the rate at which inflammation induces con-
tractile agonist release (akμ) exacerbates remodelling, and
increasing the rate of stress-induced agonist release (ac)
increases the positive mechanotransductive feedback, lead-
ing to additional remodelling (Fig. 8c). With both an
increase in stress-mediated feedback and in inflammation-
induced contractile agonist release, agonist resolution time
Fig. 7 Effect of airway smooth muscle cell hyper-responsiveness on
airway remodelling, active tone, and mechanotransductive feedback.
Variation in a remodelled geometry with inflammation frequency (ωμ)
and hyper-responsiveness (Tc) parameter values. Transmural contractile
agonist concentration is plotted as a function of radius at days 28, 30,
and 32 for parameter value pairs indicated by the circled points on a: b
where contractile agonist eventually clears from the tissue and c where
contractile agonist remains in the tissue in an indefinite feedback loop,
causing increasing remodelling long after cessation of challenges
is increased, though it remains significantly faster than with
direct contractile agonist challenge. Increasing akμ and ac
thus leads to an effective combination of inflammatory
and contractile agonist challenges, as increased contrac-
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(a) (b) (c)
(d) (e) (f)
Fig. 8 Global versus local effects on airway remodelling and active
tone. Variation in remodelled geometry (1st row) with parameter pairs:
inflammation magnitude and resolution (cdμ, aμ; 1st column), con-
tractile agonist magnitude and resolution (cdk , ak ; 2nd column), and
inflammation-induced contractile agonist release and mechanotrans-
ductive agonist release (akμ, ac; 3rd column). Circumferential stress
(2nd row) is plotted as a function of radius and time for parameter value
pairs indicated by the circled points on the surfaces
tion is observed during inflammatory challenges, and overall
remodelling is higher than with agonist challenge alone. The
higher levels of contractile agonist release during inflamma-
tory challenges result in greater mechanical stresses (Figs. 8f)
from agonist-induced bronchoconstriction.
Effect of phenotype switching and proliferation rate mod-
ulation by tensile versus compressive mechanical stress In
all of the above simulations, we have assumed that only ten-
sile stresses can increase phenotype switching (via (2.19) and
nonzero c
f
cp in (2.20)) and that the proliferation rate of the pro-
liferative ASMCs is unaffected by local stress (default value
c
f
p = 0). Here, we investigate the effect of varying these
parameters (in inflammatory-only challenges) for both ten-
sile and compressive stress-modulated phenotype switching
and proliferation/recruitment rate. We vary either the stress-
induced switching rate (c fcp) or the proliferation rate (c fp ) and
the contractile agonist clearance rate (cdk). Transmural dis-
tributions of proliferating ASMC volume fraction at day 51
(Fig. 9), selected from the overall results of this parameter
exploration (Online Resource 6), illustrate the effects of these
parameters on remodelling.
We observe similar amounts of remodelling for increases
in both tensile and compressive stress-modulated pheno-
type switching rate and decreasing agonist clearance rate
with no clear threshold effect (see Online Resource 6). For
the same parameter ranges, agonist resolution times are
observed to be similar and relatively independent of c fcp for
both cases. Distributions of the proliferative ASMC volume
fraction significantly differ in the two cases, with larger vol-
ume fractions at the outer edge of the airway wall in the
tensile stress-modulated case and at the inner edge in the
compressive stress-modulated case (Fig. 9a), reflecting the
observed circumferential stress heterogeneity and contrac-
tile agonist build-up. For our given initial conditions (Online
Resource 2), both tensile and compressive stress-induced
increase in phenotype switching results in a greater amount
of airway remodelling than stress-induced increase in pro-
liferation rate (Fig. 9a, cf. b). Agonist retention is similar
between the two cases.
4 Discussion
The mechanisms underlying the interaction of inflamma-
tion, airway hyper-responsiveness and airway remodelling
in asthma are poorly understood. Thus, we have devel-
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Fig. 9 Effect of mechanotransductive mechanisms on airway mechan-
ics and remodelling. Volume fraction of proliferating airway smooth
muscle cells as a function of radius at day 51, for either tensile (solid
lines) or compressive (dotted lines) mechanical stress-induced changes
in ASMC (a) phenotype switching rate or b proliferation rate. Param-
eters for a are cdk = 0.83 and c fcp = 0.05 and for b are cdk = 0.50
and c fp = 0.05. Increased remodelling occurs in the former, even at a
higher agonist clearance rate
oped a new computational model of coupled biochemical-
and mechanotransduction-induced remodelling of the air-
way wall. In the model, accumulation of ASM and ECM is
driven by switching of ASMCs from a contractile to prolifer-
ative phenotype (which is capable of synthesizing ECM), and
also, via a novel mechanotransductive feedback mechanism
by which a mechanically stressed tissue releases mitogenic
growth factors and contractile agonists.
Our results qualitatively match those reported for asth-
matic airways (as well as results from our previous model;
see Online Resource 7). For example, we have predicted
narrowing of the lumen and a downward shift in the pressure–
radius curves that have been previously reported in humans
(Williamson et al. 2011). Our model also predicts wall thick-
ening of airways due to increased ASM volume, which has
been reported both in asthmatic patients (James et al. 2012,
2009) and in animal models (Alrifai et al. 2014).
The inflammatory twitch hypothesis suggests that self-
limiting inflammatory events are invoked in the presence of
an allergic stimulus and dissipate as the stimulus disappears,
with long resolution periods being a possible explanation for
the chronic inflammation characteristic of asthma (Pothen
et al. 2016). Our results suggest that these long resolution
periods may increase remodelling associated with severe
asthma. In animal models of asthma, for example, transitory
inflammatory cell recruitment, and increases in thickness of
both ASM bundles and the SBM, have been associated with
repeated/successive allergen challenges (Johnson et al. 2004;
McMillan and Lloyd 2004). This response is thought to be
the effect of pro-remodelling growth factors affecting acti-
vation of mast cells, ASM proliferation and ECM deposition
(Naveed et al. 2017; James 2017) or increased recruitment
of ASM progenitors such as myofibroblasts into the ASM
bundles (Gerarduzzi and Battista 2017; Singh et al. 2014;
Saunders et al. 2009). Thicknesses of both ASM bundles and
the SBM have been shown to gradually return to control lev-
els upon cessation of challenges (Alrifai et al. 2014; Leclere
et al. 2012), with the resolution periods of inflammation and
tissue growth being on the order of days to months (Pothen
et al. 2016; Alrifai et al. 2014), which is reflected in our sim-
ulations, in which inflammatory status, μ, remains elevated
with decreased clearance rate, cdμ.
Our work broadly follows that of Skalak (1980) and
Rodriguez et al. (1994) in which growth and remodelling
is treated as a topological mapping from a reference con-
figuration to a grown configuration followed by an elastic
deformation. A key component of this model is the implicit
separation of timescales between the growth and the (instan-
taneous) elastic deformations. This approach has previously
been applied to model airway narrowing (in which the folding
that occurs during growth was modelled utilizing buck-
ling theory; Moulton and Goriely 2011a, b), but this was in
the context of a single phase, and growth kinematics were
prescribed directly. Multiphase or mixture theory has been
utilized in numerous cardiovascular studies (e.g. Valentin
et al. 2013; Gleason and Humphrey 2005; Gleason et al. 2004;
Humphrey and Rajagopal 2003, 2002), where the models
were driven by evolution of the growth configuration of each
phase, but without consideration of their interactions. To our
knowledge, the approach taken here, in which the spatio-
temporal evolution of the individual tissue constituents is
driven by underlying biological and mechanochemical pro-
cesses, has not been considered in airway remodelling. Thus,
the multiphase model proposed here addresses the limitations
of previous models by considering in detail the interactions
between tissue constituents, as in the studies of Ateshian
(2007) and Aparício et al. (2016). We use our model to carry
out a series of parameter exploration studies to identify poten-
tial mechanisms underlying the pathogenesis and evolution
of asthma, described below.
Impaired resolution of inflammation may explain airway
remodelling characteristic of asthma As in our previous
model (Chernyavsky et al. 2014), slower resolution of inflam-
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mation has a greater effect on airway wall thickening than
either challenge frequency or amplitude (Figs. 4a, 8a), as
a result of slower clearance of residual pro-remodelling
and pro-contractile cytokines (See Online Resource 7). This
effect may be responsible for increased remodelling and
bronchoconstriction observed in patients with severe asthma
that is poorly controlled with anti-inflammatory medications,
e.g. corticosteroids. In these cases, inflammation may not be
effectively cleared, e.g. by failure to induce inflammatory
cell apoptosis (Wenzel 2012; Woolley et al. 1996).
Inflammation-independent bronchoconstriction-mediated
mechanical stresses could drive airway remodelling Grainge
et al. (2011) have demonstrated the possibility of inflam-
mation-independent airway remodelling in asthmatics
through application of methacholine-only challenges. Our
model suggests the mechanisms by which this may occur. We
show how tensile stresses along (circumferentially-oriented)
muscle fibres, arising from agonist-induced contraction of
ASMCs, can cause a local release of additional agonist
(Fig. 6c). This mechanotransductive pathway may represent
stretch-induced activation of latent TGF-β, which has both
mitogenic (Halwani et al. 2011) and contractile agonist (Oji-
aku et al. 2017; Oenema et al. 2013; Desmoulière et al. 2005;
Grinnell and Ho 2002; Montesano and Orci 1988) properties.
This additional local increase in agonist concentration trig-
gers a local tensile stress-induced cell phenotype switching,
thus driving increases in ASM mass. We have also shown that
compressive stress-induced increases in phenotype switching
or proliferation rate (Fig. 9), possibly mediated by shed-
ding of growth factors such as EGFR and ET-1, could also
explain the inflammation-independent remodelling observed
in Grainge et al. (2011). Contractile agonists alone are insuf-
ficient to induce physiological changes in mice, as measured
with plethysmography (Mailhot-Larouche et al. 2018). Our
simulations suggest that very frequent challenges, impaired
agonist clearance or increased rate of stress-driven ago-
nist activation is required to cause significant remodelling
(Fig. 8b). It is possible that an intrinsic inability to clear
agonist, increased sensitivity of ASM/ECM to stress-driven
TGF-β activation or EGFR/ET-1 shedding could place the
asthmatic subject in a high-risk region of the parameter space.
Interaction of inflammation with intrinsic ASM hyper-
responsiveness could explain persistent contractile tone and
severe remodelling Our simulations show that increased
intrinsic hyper-responsiveness causes increased remodelling
(Fig. 7a) and significantly increased contractile agonist
resolution times. This response is a result of increased bron-
choconstriction at a given agonist concentration, driving
increases in tensile stresses and hence further (mechan-
otransductive) activation of pro-mitogenic mediators and
contractile agonists such as TGF-β. These results high-
light that the retention of contractile agonist associated with
increased hyper-responsiveness is a candidate mechanism
accounting for the persistent tone observed in asthmatics
(Brightling et al. 2002). As expected, long resolution times
are associated with impaired clearance of contractile agonist,
cdk (Fig. 6a). Notably, delayed contractile agonist resolution
occurs when both the ASMCs are very hyper-responsive and
inflammation challenge frequency is high. The combination
of identified mechanisms could therefore be responsible for
persistent contractile tone and remodelling, post-challenge,
in hyper-responsive airways (Kariyawasam et al. 2007).
Increased airway remodelling could occur via local
mechanotransductive effects An increase in both inflammation-
and mechanical stress-induced contractile agonist release
(Fig. 8c) leads to a condition that is an effective combination
of inflammation-only (Fig. 8a) and agonist-only challenge
(Fig. 8b). Increased rates of inflammation-induced agonist
release (akμ) could represent degranulation of the larger num-
bers of mast cells present in the ASM bundles of asthmatics
(Naveed et al. 2017) and hence the production of contractile
agonist (e.g. histamine). These released factors ultimately
elicit a pro-mitogenic response where (tensile) mechanical
stresses arising from ASMC contraction drive tissue remod-
elling via stress-induced phenotype switching of ASMCs.
Separately, under the assumption of mechanically activated
mediators (e.g. TGF-β), increasing stress-activated release
(ac) increases agonist-induced bronchoconstriction, leading
to further agonist release and thus further contraction and
stress-induced remodelling in a perpetual feedback loop. The
feedback mechanism may explain how coupled inflamma-
tion and bronchoconstriction lead to increased remodelling
in severe asthma.
Airway wall thickening may be a normal, local mechano-
protective response but ultimately becomes detrimental
to global lung mechanics and function The increase in
cross-sectional area from thickening of the SBM counter-
intuitively may serve to reduce mechanical stresses, arising
during bronchoconstriction (Fig. 5c). This reduction in stress
could, in turn, reduce compressive stress-driven shedding of
growth factors mediated by epithelial cells. Our model does
not allow for buckling of the SBM, due to our imposition
of axisymmetry, but reduced compressive stresses as a result
of the thicker SBM could also reduce propensity to buckle
(Moulton and Goriely 2011a) and hence limit airway nar-
rowing during bronchoconstriction.
Our results also indicate that remodelling-induced changes
in functional mechanical properties of the airways may
depend on what drove the remodelling. For instance, we
show that the pressure–radius curves during inflammation-
only challenges have qualitatively different characteris-
tics to those associated with agonist-only challenges (cf.
Fig. 4b, 6b).
Interaction of different underlying mechanisms may con-
tribute to the existence of different asthma phenotypes A com-
bination of various characteristics defines asthma subgroups,
123
M. R. Hill et al.
or phenotypes (see Wenzel 2012 and references therein).
Here, we have identified various parameter combinations that
may contribute to the existence of different asthma pheno-
types. For example, the presence of eosinophils in the lung
tissue is associated with thickened SBM, high expression of
TGB-β, increased frequency and severity of symptoms, and
more near-fatal events (Wenzel 2012; Miranda et al. 2004).
Persistent eosinophils, despite corticosteriod treatment (typ-
ically associated with eosinophil apoptosis), is associated
with adult-onset, less allergic severe (TH 2) asthma (Wen-
zel 2012). The slower clearance of inflammation leading to
increased remodelling (Figs. 4a, 8a) and reduced contrac-
tile agonist clearance may underlie this type of asthma. Our
results (Fig. 5) suggest that a thickened SBM may be associ-
ated with the increased presence of eosinophils, in agreement
with the SBM thickness observed in non-eosinophilic com-
pared with eosinophilic asthma (Miranda et al. 2004).
Our results show that for regular bronchoconstrictive
events to induce long-term airway remodelling an extreme
set of consequences (Figs. 6, 8b) is required, which may
be the reason why, to our knowledge, contractile agonist-
induced remodelling has not been observed in animal studies
(e.g. Mailhot-Larouche et al. 2018). However, the study by
Grainge et al. (2011) shows that contractile agonist chal-
lenges do lead to increased ASM thickness in humans. That
mice do not spontaneously develop asthma but that humans
do, suggests that the subjects of the Grainge et al. (2011)
study may lie in a different region of parameter space, i.e.
beyond the relevant thresholds.
Methacholine challenges have been shown to increase air-
way responsiveness in humans over the short term (Gazzola
et al. 2017), and increased smooth muscle responsiveness
may be independent of inflammation in some asthma phe-
notypes (e.g. non-TH 2 asthma; Wenzel 2012). Our model
suggests a possible mechanism: with intrinsically hyper-
responsive ASMCs, normal exposure to contractile agonists
alone (in the absence of inflammation) may be sufficient to
drive further agonist release (Fig. 6b), and increase ASMC
responsiveness, thus leading an asthma symptom phenotypes
not typically associated with inflammation, such as exercise-,
obesity-induced asthma, or non-TH 2 asthma.
Increased ASMC hyper-responsiveness (Fig. 7) and/or
increased mechanotransduction (Fig. 8c) may exacerbate
remodelling, even at normal levels of inflammation (pauci-
granulocytic asthma; Carr et al. 2017). Thus, these mecha-
nisms may underlie the degrees of severity associated with
inflammation-induced (TH 2) asthma: mild to moderate asth-
matics may be characterized by increased inflammation but
normal ASMC responsiveness (Fig. 4), while severe asth-
matics may have increased hyper-responsiveness that leads to
pathological remodelling (Fig. 7). Alternatively, mechanisms
that reverse influx of inflammatory cells, and hence, return
inflammation to normal levels, may have become impaired
(Pothen et al. 2016; Brightling et al. 2012). A remodelled air-
way exhibiting a combination of the characteristics described
above may be primed for severe or even fatal bronchospasms
in which airway contraction completely obstructs airflow.
Model limitations and future work Models of this nature
necessarily require some simplifying assumptions. In partic-
ular, we have assumed that the airway remains axisymmetric
(and free of shear) during both growth and elastic deforma-
tion. This simplified approach, in which only radial growth
is considered, permits more straightforward analysis of the
effects of varying concentrations of tissue constituents and
contractile agonists across the airway wall. Nevertheless, our
model is novel in accounting for local mechanotransductive
effects and these spatial distributions. However, we note that
some growth may occur circumferentially and, possibly, axi-
ally, in vivo. Circumferential growth/atrophy has been shown
to underlie the development of residual stresses in arteries
(Rodriguez et al. 1994); however, airways have been shown
to exhibit little or no residual stresses (McKay et al. 2002),
and so we omit this growth mode from the model for sim-
plicity. Axial growth is similarly neglected, based on a lack
of experimental data on axial growth of airways. The growth
models of Ren (2013) and Grytsan et al. (2017) do account
for both isotropic and varying degrees of anisotropic growth
but do not consider heterogeneous spatial distributions. A
more comprehensive approach would be to extend the mod-
els analysed herein to 3D. However, the numerical solution
of the resulting equations is beyond the scope of the current
study. Additionally, our imposition of axisymmetry prevents
us from considering buckling of the stiff SBM. Future work
could involve utilizing this model to predict regions of high
compressive stresses in which buckling could occur (Moul-
ton and Goriely 2011a).
To solve (2.27), we specify zero radial velocity at the outer
wall, so that growth occurs inwardly. We note that this choice
is somewhat arbitrary and that the growth velocity could be
specified at any point along the wall thickness. We choose
to specify zero growth on the outer boundary based on evi-
dence that airways appear to narrow during asthma. Studies
on human bronchial segments have shown that increased
ASM in asthmatics contributes to exaggerated airway nar-
rowing (Noble et al. 2013).
We do not allow for the separate evolution of the individ-
ual constituents’ reference configurations, as in Humphrey
and Rajagopal (2002). If our assumptions were relaxed so
that these could move independently, interphase drag may be
used to more accurately account for stress-induced activation
of latent TGF-β. Moreover, changes in reference configura-
tions, in addition to non-axisymmetric growth, could allow
for the development of residual stresses. Although healthy
airways exhibit negligible or small residual stresses (McKay
et al. 2002), to our knowledge these have not been mea-
sured in remodelled airways. Relaxing this constraint would
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present a challenge in the theoretical development and in the
numerical solution that is beyond the scope of the current
work.
We have assumed that collagen fibre recruitment initiates
at stretches above unity, with an exponential function rep-
resenting gradually increasing fibre uncrimping. Rigorous
experimental analysis of the airway structure–function rela-
tionship, through coupled mechanical testing and advanced
microscopic imaging (e.g. Hill et al. 2012; Clifford et al.
2011), would enable incorporation of fibre dispersion and
recruitment to refine our model (e.g. Gasser et al. 2006;
Sacks 2003; Lanir 1983, 1979). Also, we have not accounted
for diffusion of applied contractile agonists, or of activated
cytokines such as TGF-β. Finally, migration of myofibrob-
lasts (ASM progenitors) into the muscle bundle has been
hypothesized as a mechanism of increased ASM. Although
this migration (and differentiation into ASMCs) has not
been modelled here explicitly, the ASMC proliferation in
our model could instead represent this recruitment of ASM
progenitors, and the timescale associated with migration is
implicitly accounted for in the proliferation rate (reinter-
preted as a ‘recruitment’ rate of myofibroblasts which then
become ASM).
Notwithstanding these limitations, key advantages of our
model are the ability to generate measurable biological and
mechanical output that may be tested experimentally and the
ability to separate the long-term effects of growth from the
relatively shorter term mechanical effects of pressurization
and active contraction. A study, combining the modelling
approach described here with experimental measurements
of tissue constitution, geometry, and active mechanics, is
required to distinguish between the effects of geometric
remodelling and changes in tissue mechanics.
Therefore, this work forms the theoretical basis of a model
that is currently being tested against data from in vivo animal
experiments, utilizing an ovalbumin model of inflammation-
induced asthma in mice. We have shown how the volume
fraction of constituents may be evaluated at any time along
the remodelling process (e.g. Fig. 4). These will be compared
to measurements made on histological sections taken from
animal models of asthma, to infer underlying mechanisms as
discussed above, and also for further model development and
validation. Additionally, we have demonstrated the ability to
assess mechanical properties of the airway as they evolve,
via computed pressure-radius curves (e.g. Fig. 4b) which
are commonly measured experimentally, to show changes in
passive and active tissue mechanics and distinguish between
healthy and diseased airways.
In addition to airway remodelling, the approach out-
lined in this paper has broad applicability to other areas
of tissue mechanics. For example, the mechanotransduc-
tive feedback mechanisms described herein likely have
direct applications to models of aneurysm growth (Gryt-
san et al. 2017; Aparício et al. 2016). Moreover, the
coupled biochemical–biomechanical elements are relevant
to inflammation-associated adventitial collagen deposition
observed in arteries under hypertension (Bersi et al. 2016).
Furthermore, the technique we present for modelling a
non-homogeneous spatial distribution of tissue constituents
would be applicable to the myocardium, since local changes
in tissue constitution occur during mechanical overload,
e.g. in hypertension-induced myocyte hypertrophy and col-
lagen deposition (Hill et al. 2014) and during remod-
elling following myocardial infarction (Gajarsa and Kloner
2011).
Conclusions Our results suggest that mechanical stresses,
arising from bronchoconstriction, initiated by multiple
inflammatory or contractile agonist challenges, and driving
agonist release, generate a mechanotransductive feedback
loop. With this feedback loop, increased ASM hyper-
responsiveness to contractile agonists and impaired clearance
of inflammatory factors and contractile agonists leads to
increased remodelling, increased bronchoconstriction, and
maintenance of an increased baseline contractile tone due to
the chronic presence of contractile agonists. The key factors
that allow such a state to emerge are (i) increased intrin-
sic hyper-responsiveness of ASMCs to contractile agonists,
(ii) delayed contractile agonist clearance from the tissue,
(iii) increased release of contractile agonist by inflamma-
tory cells, and (iv) mechanotransductive feedback, in which
active contraction generates increases in mechanical stress
that subsequently initiate the release of additional contractile
agonists and thus exacerbate remodelling. Targeting mechan-
otransductive pathways (e.g. TGF-β) and rapid resolution of
inflammation or contractile agonist may have potential for
treating severe forms of asthma.
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